Area studies

Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays

Retrieved on: 
Tuesday, March 5, 2024

FREMONT, Calif., March 5, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the commercial launch of the NULISAseq CNS Disease Panel 120 for highly multiplexed protein analysis of all the critical pathways implicated in major neurological disorders, and the NULISAqpcr pTau-217 Assay (ALZpath antibody) for focused studies of this important biomarker in dementia research. Both assays benefit from the unparalleled sensitivity of the NULISA™ chemistry and are run on the fully automated ARGO™ HT System that streamlines the time to complete large cohort studies. The launch of these two products represents another important milestone in the company's goal to deliver high-sensitivity protein analysis from biofluids to enable earlier diagnosis of disease and better prediction of therapeutic outcomes. The products are expected to ship in Q2 2024. 

Key Points: 
  • Data demonstrating the superior performance over existing assays highlighted at the Alzheimer's Disease and Parkinson's Disease (AD/PD™ 2024) international conference in Lisbon, Portugal.
  • Both assays benefit from the unparalleled sensitivity of the NULISA™ chemistry and are run on the fully automated ARGO™ HT System that streamlines the time to complete large cohort studies.
  • The Alamar products represent a significant advancement in Alzheimer's Disease research, says Dr. Henrik Zetterberg.
  • This research depends on the availability of biomarkers to detect disease earlier and distinguish between highly related dementia disorders.

Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays

Retrieved on: 
Tuesday, March 5, 2024

FREMONT, Calif., March 5, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the commercial launch of the NULISAseq CNS Disease Panel 120 for highly multiplexed protein analysis of all the critical pathways implicated in major neurological disorders, and the NULISAqpcr pTau-217 Assay (ALZpath antibody) for focused studies of this important biomarker in dementia research. Both assays benefit from the unparalleled sensitivity of the NULISA™ chemistry and are run on the fully automated ARGO™ HT System that streamlines the time to complete large cohort studies. The launch of these two products represents another important milestone in the company's goal to deliver high-sensitivity protein analysis from biofluids to enable earlier diagnosis of disease and better prediction of therapeutic outcomes. The products are expected to ship in Q2 2024. 

Key Points: 
  • Data demonstrating the superior performance over existing assays highlighted at the Alzheimer's Disease and Parkinson's Disease (AD/PD™ 2024) international conference in Lisbon, Portugal.
  • Both assays benefit from the unparalleled sensitivity of the NULISA™ chemistry and are run on the fully automated ARGO™ HT System that streamlines the time to complete large cohort studies.
  • We have also partnered with ALZpath, Inc. to bring the performance of their industry standard pTau217 antibody to a new level of sensitivity."
  • This research depends on the availability of biomarkers to detect disease earlier and distinguish between highly related dementia disorders.

Central Japan Startup Ecosystem Holds Symposium on "Homeland of Mobility 5.0 - Leading Society to the Next Generation"

Retrieved on: 
Friday, March 1, 2024

The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."

Key Points: 
  • The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."
  • The event effectively communicated the strength of the Central Japan Ecosystem to overseas media and successfully achieved coverage in key media.
  • Toshio Sumi (Director, Economic Affairs Bureau Startup Support Office, Innovation Department, Nagoya City Economic Affairs Bureau) provided an overview of Central Japan, its history of innovation and manufacturing, and initiatives from the Central Japan Startup Ecosystem.
  • Central Japan Startup Ecosystem provides everything a startup needs – from highly trained workers in many specialized fields to opportunities to conduct feasibility studies with leading companies in various industries including the mobility sector.

Central Japan Startup Ecosystem Holds Symposium on "Homeland of Mobility 5.0 - Leading Society to the Next Generation"

Retrieved on: 
Friday, March 1, 2024

The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."

Key Points: 
  • The symposium was a hybrid event focusing on Central Japan's commitment to being the "Homeland of Mobility 5.0 - Leading Society to the Next Generation."
  • The event effectively communicated the strength of the Central Japan Ecosystem to overseas media and successfully achieved coverage in key media.
  • Toshio Sumi (Director, Economic Affairs Bureau Startup Support Office, Innovation Department, Nagoya City Economic Affairs Bureau) provided an overview of Central Japan, its history of innovation and manufacturing, and initiatives from the Central Japan Startup Ecosystem.
  • Central Japan Startup Ecosystem provides everything a startup needs – from highly trained workers in many specialized fields to opportunities to conduct feasibility studies with leading companies in various industries including the mobility sector.

Lummus Consultants Launches New Website

Retrieved on: 
Thursday, February 29, 2024

HOUSTON, Feb. 29, 2024 /PRNewswire/ -- Lummus Technology announced the launch of Lummus Consultants' new website, www.lummusconsultants.com. The new site reflects comprehensive information on the company's service offerings, industry information and real-life examples of how Lummus Consultants serves its clientele.

Key Points: 
  • HOUSTON, Feb. 29, 2024 /PRNewswire/ -- Lummus Technology announced the launch of Lummus Consultants' new website, www.lummusconsultants.com .
  • The new site reflects comprehensive information on the company's service offerings, industry information and real-life examples of how Lummus Consultants serves its clientele.
  • Lummus Consultants, a wholly owned business of Lummus Technology, acts as the lender's engineers and helps companies understand the technical, commercial and environmental factors involved in a potential investment, venture or project, providing an independent, fully objective and thorough assessment that helps strengthen decision making, mitigate project risks and advance sustainable operations.
  • The new website will be continually updated with new service offerings, corporate milestones, news and articles.

Stagwell (STGW) Launches 'Unlock Surveys' Panel as the Demand for Consumer Research Booms in 2024

Retrieved on: 
Monday, February 26, 2024

NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, has unveiled "Unlock Surveys," a new global research community, providing brands and researchers with real-time access to the opinions and insights of hundreds of thousands of verified, trustworthy consumers across international markets. The panel aims to add over 200,000 new active survey members in 2024 and sits within the Stagwell Marketing Cloud (SMC) suite of data-driven SaaS products for modern marketers.

Key Points: 
  • The panel aims to add over 200,000 new active survey members in 2024 and sits within the Stagwell Marketing Cloud (SMC) suite of data-driven SaaS products for modern marketers.
  • "Unlock Surveys is arguably the most significant research panel launched in nearly a decade, in an industry that has seen research means consolidated, leading to commoditization, poor data quality and high participant turnover," said Mark Penn, chairman and CEO, Stagwell.
  • "We're building Unlock Surveys in a way that connects with authentic people and is underpinned by proven, time-tested research principles."
  • These panels have been built to score highly in any "research on research" metric such as quality, consistency, and census representation.

NextPlane Brings GenAI and Seamless Interconnection Between Microsoft Teams, UCaaS, and CX Platforms

Retrieved on: 
Wednesday, February 21, 2024

NextPlane enables subscribers to upgrade their Microsoft Teams calls with an advanced AI companion that transcribes and analyzes voice and video calls.

Key Points: 
  • NextPlane enables subscribers to upgrade their Microsoft Teams calls with an advanced AI companion that transcribes and analyzes voice and video calls.
  • NextPlane serves as a dynamic interoperability layer, future-proofing integration with the Microsoft Graph API or SIP Gateway.
  • This latest feature enhances CX platforms by matching consumers with agents using sentiment analysis for personalized interactions.
  • NextPlane OpenAxys functions as an abstraction layer, bridging the gap between UC platforms, custom applications, AI tools, and LLMs.

Cutting Edge Data Reveals Improved Sensitivity of PD Motor Progression with Wearable Sensors, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, February 21, 2024

TORONTO, Feb. 21, 2024 /PRNewswire-PRWeb/ -- The development and deployment of disease-modifying interventions for Parkinson's disease (PD) have been limited due to a lack of objective, accurate and reliable measures of progression. As such, the adoption of digital technologies has increased in recent years with the intent to overcome the poor sensitivity of conventional rating scales currently used as the gold standard in clinical trials. However, natural history studies incorporating digital motor endpoints in PD are sparse. Excitingly, data recently published from key longitudinal studies reveal cutting-edge evidence demonstrating that digital endpoints of motor progression are more sensitive than conventional clinical scales.

Key Points: 
  • The featured speakers will discuss how (by capturing a composite score of digital measures of bradykinesia with wearable sensors) a better signal of disease progression can be obtained compared to independent measurements.
  • Attendees will gain insights into the future directions of wearable sensors and digital motor endpoints in clinical trials to monitor the progression of neurodegenerative diseases.
  • TORONTO, Feb. 21, 2024 /PRNewswire-PRWeb/ -- The development and deployment of disease-modifying interventions for Parkinson's disease (PD) have been limited due to a lack of objective, accurate and reliable measures of progression.
  • Excitingly, data recently published from key longitudinal studies reveal cutting-edge evidence demonstrating that digital endpoints of motor progression are more sensitive than conventional clinical scales.

CAAS, EDB AND SUPERNAL INK STRATEGIC PARTNERSHIPS TO DEVELOP ADVANCED AIR MOBILITY IN ASIA-PACIFIC REGION

Retrieved on: 
Tuesday, February 20, 2024

EDB and Supernal will also share knowledge and resources to support the development of AAM operational strategies.

Key Points: 
  • EDB and Supernal will also share knowledge and resources to support the development of AAM operational strategies.
  • This includes conducting market analyses and viability studies to assess the feasibility of AAM in Singapore and focuses on identifying unique applications in Singapore and the Asia-Pacific region.
  • 5          "Working with EDB and CAAS exemplifies how collaboration between government and industry can help make AAM a reality," said Shin.
  • In November last year, CAAS convened the first-ever meeting of Asia-Pacific regulators and engagement with industry for this purpose.

AITX’s RAD Announces ATM Hook & Chain Attack AI Analytic

Retrieved on: 
Thursday, February 15, 2024

Detroit, Michigan, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Robotic Assistance Devices (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), today announced a significant addition to its suite of AI analytics. This innovation equips RAD's robotic security solutions with the capability to detect the rampant threat of Hook & Chain ATM attacks plaguing the banking industry. A Hook and Chain attack involves attaching one end of a chain or cable to an ATM and using a vehicle to exert force on the machine, usually by pulling the chain with the vehicle, with the objective of forcefully open the ATM's safe doors, allowing thieves to access the cash inside. With this development, RAD continues to lead the charge in providing cutting-edge security solutions tailored to meet the evolving challenges faced by financial institutions and other enterprise clients.

Key Points: 
  • This innovation equips RAD's robotic security solutions with the capability to detect the rampant threat of Hook & Chain ATM attacks plaguing the banking industry.
  • Hook and chain attacks were the leading ATM crime, in which thieves steal the cash from an ATM machine and cause extensive property damage, sometimes with loss and damages approaching $500K per incident.
  • Mark Folmer, CPP, PSP, FSyI, President of RAD, added, “The Hook & Chain analytic was requested during discussions with a leading national bank with over 1000 branches.
  • We currently have highly satisfied banking clients who are eager to implement the ATM attack detection analytic.